DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202356

Anaesthetic management of a young primigravida with 8 months amenorrhea, rheumatic heart disease, hypothyroidism and met-hemoglobinimea schedule for cesarean section

Misha Katyal

Abstract


A young patient, primigravida with rheumatic heart disease, hypothyroidism and met-hemoglobinemia had central and peripheral cyanosis was scheduled for caesarean section under general anesthesia in two days. Author managed met-hemoglobinemia with ascorbic acid keeping methylene blue as standby. Haemoglobin saturation was 89% at room air and 92% with supplemental oxygen. Initial met-haemoglobin levels were 31.54% (normal values <1%). After optimizing thyroid and RHD status (moderate MR and mild MS), she was given tablet ascorbic acid 2 gram thrice a day with methylene blue as standby. Conventional balanced general anesthesia technique was used and she was followed up in postoperative period with ICU care. A healthy live female baby was extracted and mother had stable vital parameters. Postoperative treatment with ascorbic acid was continued. Repeated methaemoglobin levels showed a drop from preoperative value of 31.54% to 11.39% by 3rd postoperative day and 8.05% at the end of 1st week. At the time of discharge, she did not have any cyanosis. Ascorbic acid is a good alternative drug with limited experience in met-hemoglobinemia. Author present a case of a met-hemoglobinemia treated with ascorbic acid successfully to emphasize the use of ascorbic acid as an alternative method without any adverse effects.


Keywords


Ascorbic acid, Cesarean section, Met-hemoglobinemia

Full Text:

PDF

References


Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: Etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646-56.

Rinder CS. Haematologic disorders: in Roberta L. Hines, Katherine E. Marschall (eds); Stoelting’s Anesthesia and Co-existing Disease. 5th ed. Philadelphia: Churchill livingstone; 2008:415.

Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51:434-44.

Lee KW, Lee JB. Antidote for acquired methemoglobinemia: methylene blue. J Korean Med Assoc. 2013;56(12):1084-90.

Topal H, Topal Y. Toxic methemoglobinemia treated with ascorbic acid: case report. Iran Red Crescent Med J. 2013;15(12):e12718.

Atyabi N, Yasini SP, Jalali SM, Shaygan H. Antioxidant effect of different vitamins on methemoglobin production: An in vitro study. Veterinary Res Forum. 2012;3(2):97-101.